Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review

Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review

Abstract Denosumab, a monoclonal antibody that specifically targets cytokine receptor activator of nuclear factor‐kappa B ligand (RANKL), is a potentially viable option in resistant aneurysmal bone cysts.

Guardado en:
Detalles Bibliográficos
Autores principales: Pedram Fadavi, Amir Mohammad Arefpour, Ramyar Hariri, Maryam Vasheghani, Maryam Garousi, Farzad Taghizadeh‐Hesary
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
aneurysmal bone cyst
denosumab
management
RANK ligand
resistant
Medicine
R
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/194a51330c38431eb7d573915ca4f657
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:194a51330c38431eb7d573915ca4f657
record_format dspace
spelling oai:doaj.org-article:194a51330c38431eb7d573915ca4f6572021-12-02T07:55:57ZDramatic response of aneurysmal bone cyst to denosumab: Case report and literature review2050-090410.1002/ccr3.4993https://doaj.org/article/194a51330c38431eb7d573915ca4f6572021-10-01T00:00:00Zhttps://doi.org/10.1002/ccr3.4993https://doaj.org/toc/2050-0904Abstract Denosumab, a monoclonal antibody that specifically targets cytokine receptor activator of nuclear factor‐kappa B ligand (RANKL), is a potentially viable option in resistant aneurysmal bone cysts.Pedram FadaviAmir Mohammad ArefpourRamyar HaririMaryam VasheghaniMaryam GarousiFarzad Taghizadeh‐HesaryWileyarticleaneurysmal bone cystdenosumabmanagementRANK ligandresistantMedicineRMedicine (General)R5-920ENClinical Case Reports, Vol 9, Iss 10, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic aneurysmal bone cyst
denosumab
management
RANK ligand
resistant
Medicine
R
Medicine (General)
R5-920
spellingShingle aneurysmal bone cyst
denosumab
management
RANK ligand
resistant
Medicine
R
Medicine (General)
R5-920
Pedram Fadavi
Amir Mohammad Arefpour
Ramyar Hariri
Maryam Vasheghani
Maryam Garousi
Farzad Taghizadeh‐Hesary
Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review
description Abstract Denosumab, a monoclonal antibody that specifically targets cytokine receptor activator of nuclear factor‐kappa B ligand (RANKL), is a potentially viable option in resistant aneurysmal bone cysts.
format article
author Pedram Fadavi
Amir Mohammad Arefpour
Ramyar Hariri
Maryam Vasheghani
Maryam Garousi
Farzad Taghizadeh‐Hesary
author_facet Pedram Fadavi
Amir Mohammad Arefpour
Ramyar Hariri
Maryam Vasheghani
Maryam Garousi
Farzad Taghizadeh‐Hesary
author_sort Pedram Fadavi
title Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review
title_short Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review
title_full Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review
title_fullStr Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review
title_full_unstemmed Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review
title_sort dramatic response of aneurysmal bone cyst to denosumab: case report and literature review
publisher Wiley
publishDate 2021
url https://doaj.org/article/194a51330c38431eb7d573915ca4f657
work_keys_str_mv AT pedramfadavi dramaticresponseofaneurysmalbonecysttodenosumabcasereportandliteraturereview
AT amirmohammadarefpour dramaticresponseofaneurysmalbonecysttodenosumabcasereportandliteraturereview
AT ramyarhariri dramaticresponseofaneurysmalbonecysttodenosumabcasereportandliteraturereview
AT maryamvasheghani dramaticresponseofaneurysmalbonecysttodenosumabcasereportandliteraturereview
AT maryamgarousi dramaticresponseofaneurysmalbonecysttodenosumabcasereportandliteraturereview
AT farzadtaghizadehhesary dramaticresponseofaneurysmalbonecysttodenosumabcasereportandliteraturereview
_version_ 1718399086469578752

Ejemplares similares